Abstract: This study presents a deep reinforcement learning–based control architecture with an adaptive sensor fusion module for complex, sensor-driven autonomous systems. The agent, trained in ...
Abstract: We propose a novel approach for removing noise from multiple reflections based on an adaptive randomized-order empirical mode decomposition (EMD) framework. We first flatten the primary ...
A quadruped robot has learned to walk across slippery, uneven terrain entirely through simulation, without any human-designed gaits or manual tuning. The system relies on deep reinforcement learning ...
Doubly-ranked (DR) stratification is a nonparametric, simple yet powerful method for instrument variable (IV) analysis and Mendelian randomization (MR) studies to create sub-groups, known as "strata", ...
The kinase inhibitor will be evaluated in patients with newly diagnosed glioblastoma. The Global Coalition for Adaptive Research (GCAR) and AstraZeneca have reached an agreement to evaluate ...
Observational studies have indicated a potential association between autoimmune diseases and the occurrence of Osteoarthritis (OA), with an increased risk of mortality among affected patients. However ...
A recent review of randomization methods used in large multicenter clinical trials within the National Institutes of Health Stroke Trials Network identified preservation of treatment allocation ...
Causal role of immune cells in chronic obstructive pulmonary disease: Mendelian randomization study.
Innate and adaptive immunity play different roles in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, previous studies on the relationship between immune cells and COPD ...
Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits In the article that accompanies this ...
ARCADIA indicates Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke; ASPIRE, Anticoagulation in ICH Survivors for Stroke Prevention and Recovery; DEFUSE 3, ...
AUSTIN, Texas--(BUSINESS WIRE)--Berry Consultants, LLC announced today that it is discontinuing its involvement in the I-SPY trials in neoadjuvant breast cancer. Beginning in 2009, Donald Berry, PhD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results